{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:22:55Z","timestamp":1728447775485},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Advanced atherosclerotic lesions are characterized by lipid accumulation, inflammation, and defective efferocytosis. An ideal therapy should address all aspects of this multifactorial disease. Ixmyelocel-T therapy, an expanded autologous multicellular therapy showing clinical promise in the treatment of diseases associated with advanced atherosclerosis, includes a novel population of M2-like macrophages. Here, we examine the macrophages of ixmyelocel-T and determine their ability to influx modified cholesterol in an atheroprotective manner, maintaining cholesterol homeostasis and preventing cellular dysfunction and death, ultimately promoting reverse cholesterol efflux.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Approximately 50 ml of whole bone marrow was obtained from healthy donors and shipped overnight. Bone marrow mononuclear cells (BMMNCs) were produced by using density gradient separation and cultured for approximately 12 days to generate ixmyelocel-T. CD14+ cells were isolated from ixmyelocel-T via positive selection for analysis. Ixmyelocel-T and human leukemia monocyte (THP-1) cells were loaded with acetylated low-density lipoprotein (Ac-LDL) for analysis. Flow cytometry and immunofluorescence were used to examine Ac-LDL uptake, expression of cytokines was analyzed by enzyme-linked immunofluorescence assay (ELISA), and quantitative real-time PCR was used to analyze expression of cholesterol-transport genes. Both the <jats:italic>in vitro<\/jats:italic> cholesterol efflux assay and <jats:italic>in vivo<\/jats:italic> reverse cholesterol transport assay were used to examine cholesterol transport.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Ixmyelocel-T macrophages take up acetylated low-density lipoprotein and express the scavenger receptors <jats:italic>CD36<\/jats:italic> and <jats:italic>scavenger receptor-B1 (SR-B1)<\/jats:italic>. Ixmyelocel-T did not become apoptotic or proinflammatory after lipid loading. The cholesterol transporter genes <jats:italic>ABAC1<\/jats:italic> and <jats:italic>ABCG1<\/jats:italic> were both statistically significantly upregulated when ixmyelocel-T macrophages were loaded with cholesterol. Ixmyelocel-T also exhibited enhanced apolipoprotein A-I (ApoAI)-mediated cholesterol efflux. In addition, <jats:italic>in vivo<\/jats:italic> reverse cholesterol-transport assay demonstrated that ixmyelocel-T was able to efflux cholesterol in this model.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Ixmyelocel-T macrophages influx modified cholesterol, remained anti-inflammatory in the face of lipid loading and inflammatory challenge, and displayed enhanced cholesterol efflux capabilities. These combined features suggest that this autologous multicellular therapy may exert beneficial effects in atherosclerotic diseases.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/scrt346","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T10:05:56Z","timestamp":1383300356000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases"],"prefix":"10.1186","volume":"4","author":[{"given":"Kelly J","family":"Ledford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Zeigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnda L","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5551\/jat.13425","volume":"20","author":"S Yao","year":"2012","unstructured":"Yao S, Zong C, Zhang Y, Sang H, Yang M, Jiao P, Fang Y, Yang N, Song G, Qin S: Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression. J Atheroscler Thromb. 2012, 20: 94-107.","journal-title":"J Atheroscler Thromb"},{"key":"483_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11883-012-0274-8","volume":"14","author":"I Hilgendorf","year":"2012","unstructured":"Hilgendorf I, Swirski FK: Making a difference: monocyte heterogeneity in cardiovascular disease. Curr Atheroscler Rep. 2012, 14: 450-459. 10.1007\/s11883-012-0274-8.","journal-title":"Curr Atheroscler Rep"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","volume":"108","author":"G Chinetti-Gbaguidi","year":"2011","unstructured":"Chinetti-Gbaguidi G, Baron M, Bouhlel MA, Vanhoutte J, Copin C, Sebti Y, Derudas B, Mayi T, Bories G, Tailleux A, Haulon S, Zawadzki C, Jude B, Staels B: Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ Res. 2011, 108: 985-995. 10.1161\/CIRCRESAHA.110.233775.","journal-title":"Circ Res"},{"key":"483_CR4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3181\/0805-RM-144","volume":"233","author":"J Pou","year":"2008","unstructured":"Pou J, Rebollo A, Roglans N, Sanchez RM, Vazquez-Carrera M, Laguna JC, Pedro-Botet J, Alegret M: Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages. Exp Biol Med (Maywood). 2008, 233: 1572-1582. 10.3181\/0805-RM-144.","journal-title":"Exp Biol Med (Maywood)"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/erc.11.16","volume":"9","author":"S Ghosh","year":"2011","unstructured":"Ghosh S: Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Exp Rev Cardiovasc Ther. 2011, 9: 329-340. 10.1586\/erc.11.16.","journal-title":"Exp Rev Cardiovasc Ther"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I: Macrophages in the pathogenesis of atherosclerosis. Cell. 2011, 145: 341-355. 10.1016\/j.cell.2011.04.005.","journal-title":"Cell"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"E474","DOI":"10.1152\/ajpendo.90369.2008","volume":"297","author":"S Hongo","year":"2009","unstructured":"Hongo S, Watanabe T, Arita S, Kanome T, Kageyama H, Shioda S, Miyazaki A: Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. Am J Physiol Endocrinol Metab. 2009, 297: E474-E482. 10.1152\/ajpendo.90369.2008.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1194\/jlr.M008441","volume":"51","author":"S Sankaranarayanan","year":"2010","unstructured":"Sankaranarayanan S, de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Weibel GL, Rothblat GH: Importance of macrophage cholesterol content on the flux of cholesterol mass. J Lipid Res. 2010, 51: 3243-3249. 10.1194\/jlr.M008441.","journal-title":"J Lipid Res"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"R967","DOI":"10.1152\/ajpregu.00277.2011","volume":"301","author":"J Bie","year":"2011","unstructured":"Bie J, Zhao B, Ghosh S: Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice. Am J Physiol Regul Integr Comp Physiol. 2011, 301: R967-R974. 10.1152\/ajpregu.00277.2011.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"483_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.110.009704","volume":"124","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto S, Tanigawa H, Li X, Komaru Y, Billheimer JT, Rader DJ: Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Circulation. 2011, 124: 1382-1390. 10.1161\/CIRCULATIONAHA.110.009704.","journal-title":"Circulation"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","volume":"113","author":"M Cuchel","year":"2006","unstructured":"Cuchel M, Rader DJ: Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?. Circulation. 2006, 113: 2548-2555. 10.1161\/CIRCULATIONAHA.104.475715.","journal-title":"Circulation"},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stem.2012.07.009","volume":"11","author":"BT Suratt","year":"2012","unstructured":"Suratt BT, Fessler MB: Greasing the way: the ABCs of HSPC efflux from the marrow. Cell Stem Cell. 2012, 11: 143-144. 10.1016\/j.stem.2012.07.009.","journal-title":"Cell Stem Cell"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/ATVBAHA.109.196105","volume":"30","author":"M Cuchel","year":"2010","unstructured":"Cuchel M, Lund-Katz S, de la Llera-Moya M, Millar JS, Chang D, Fuki I, Rothblat GH, Phillips MC, Rader DJ: Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages. Arterioscler Thromb Vasc Biol. 2010, 30: 526-532. 10.1161\/ATVBAHA.109.196105.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","volume":"6","author":"MA Bouhlel","year":"2007","unstructured":"Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G: PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007, 6: 137-143. 10.1016\/j.cmet.2007.06.010.","journal-title":"Cell Metab"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.4049\/jimmunol.181.8.5646","volume":"181","author":"C Jennewein","year":"2008","unstructured":"Jennewein C, Kuhn AM, Schmidt MV, Meilladec-Jullig V, von Knethen A, Gonzalez FJ, Brune B: Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J Immunol. 2008, 181: 5646-5652.","journal-title":"J Immunol"},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM: The many faces of macrophage activation. J Leukoc Biol. 2003, 73: 209-212. 10.1189\/jlb.0602325.","journal-title":"J Leukoc Biol"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1479-5876-5-11","volume":"5","author":"K Deonarine","year":"2007","unstructured":"Deonarine K, Panelli MC, Stashower ME, Jin P, Smith K, Slade HB, Norwood C, Wang E, Marincola FM, Stroncek DF: Gene expression profiling of cutaneous wound healing. J Transl Med. 2007, 5: 11-10.1186\/1479-5876-5-11.","journal-title":"J Transl Med"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","volume":"29","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Garlanda C, Locati M: Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009, 29: 1419-1423. 10.1161\/ATVBAHA.108.180497.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"483_CR19","doi-asserted-by":"publisher","first-page":"e8852","DOI":"10.1371\/journal.pone.0008852","volume":"5","author":"J Khallou-Laschet","year":"2010","unstructured":"Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, Dussiot M, Levillain O, Graff-Dubois S, Nicoletti A, Caligiuri G: Macrophage plasticity in experimental atherosclerosis. PLoS One. 2010, 5: e8852-10.1371\/journal.pone.0008852.","journal-title":"PLoS One"},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.imbio.2011.05.010","volume":"216","author":"OM Pello","year":"2011","unstructured":"Pello OM, Silvestre C, De Pizzol M, Andres V: A glimpse on the phenomenon of macrophage polarization during atherosclerosis. Immunobiology. 2011, 216: 1172-1176. 10.1016\/j.imbio.2011.05.010.","journal-title":"Immunobiology"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11883-012-0240-5","volume":"14","author":"MA Hoeksema","year":"2012","unstructured":"Hoeksema MA, Stoger JL, de Winther MP: Molecular pathways regulating macrophage polarization: implications for atherosclerosis. Curr Atheroscler Rep. 2012, 14: 254-263. 10.1007\/s11883-012-0240-5.","journal-title":"Curr Atheroscler Rep"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/emmm.201201374","volume":"4","author":"L Cardilo-Reis","year":"2012","unstructured":"Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, Weber C, Wagner O, Stangl H, Soehnlein O, Binder CJ: Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med. 2012, 4: 1072-1086. 10.1002\/emmm.201201374.","journal-title":"EMBO Mol Med"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"e39790","DOI":"10.1371\/journal.pone.0039790","volume":"7","author":"JE Feig","year":"2012","unstructured":"Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O: Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS One. 2012, 7: e39790-10.1371\/journal.pone.0039790.","journal-title":"PLoS One"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/scrt117","volume":"3","author":"RL Bartel","year":"2012","unstructured":"Bartel RL, Cramer C, Ledford K, Longcore A, Parrish C, Stern T, Watling S, Zeigler F: The Aastrom experience. Stem Cell Res Ther. 2012, 3: 26-10.1186\/scrt117.","journal-title":"Stem Cell Res Ther"},{"key":"483_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0209115","volume":"86","author":"E Thorp","year":"2009","unstructured":"Thorp E, Tabas I: Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 2009, 86: 1089-1095. 10.1189\/jlb.0209115.","journal-title":"J Leukoc Biol"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF02041244","volume":"47","author":"J Auwerx","year":"1991","unstructured":"Auwerx J: The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia. 1991, 47: 22-31. 10.1007\/BF02041244.","journal-title":"Experientia"},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"E1820","DOI":"10.1152\/ajpendo.00315.2007","volume":"293","author":"M Napolitano","year":"2007","unstructured":"Napolitano M, De Pascale C, Wheeler-Jones C, Botham KM, Bravo E: Effects of lycopene on the induction of foam cell formation by modified LDL. Am J Physiol Endocrinol Metab. 2007, 293: E1820-E1827. 10.1152\/ajpendo.00315.2007.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"483_CR28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-2275(20)37280-1","volume":"38","author":"Y Huang","year":"1997","unstructured":"Huang Y, Ghosh MJ, Lopes-Virella MF: Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes. J Lipid Res. 1997, 38: 110-120.","journal-title":"J Lipid Res"},{"key":"483_CR29","first-page":"1608","volume":"2012","author":"DR Michael","year":"1822","unstructured":"Michael DR, Salter RC, Ramji DP: TGF-beta inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: a dominant role for Smad-2. Biochim Biophys Acta. 1822, 2012: 1608-1616.","journal-title":"Biochim Biophys Acta"},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/mt.2009.151","volume":"17","author":"D Yin","year":"2009","unstructured":"Yin D, Wang Z, Gao Q, Sundaresan R, Parrish C, Yang Q, Krebsbach PH, Lichtler AC, Rowe DW, Hock J, Liu P: Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP. Mol Ther. 2009, 17: 1967-1978. 10.1038\/mt.2009.151.","journal-title":"Mol Ther"},{"key":"483_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1743-7075-9-25","volume":"9","author":"W Annema","year":"2012","unstructured":"Annema W, Tietge UJ: Regulation of reverse cholesterol transport: a comprehensive appraisal of available animal studies. Nutr Metab (Lond). 2012, 9: 25-10.1186\/1743-7075-9-25.","journal-title":"Nutr Metab (Lond)"},{"key":"483_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/153537020523000105","volume":"230","author":"RS Rosenson-Schloss","year":"2005","unstructured":"Rosenson-Schloss RS, Chnari E, Brieva TA, Dang A, Moghe PV: Glutathione preconditioning attenuates Ac-LDL-induced macrophage apoptosis via protein kinase C-dependent Ac-LDL trafficking. Exp Biol Med (Maywood). 2005, 230: 40-48.","journal-title":"Exp Biol Med (Maywood)"},{"key":"483_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1258\/ebm.2010.010308","volume":"236","author":"ZZ Zhao","year":"2011","unstructured":"Zhao ZZ, Wang Z, Li GH, Wang R, Tan JM, Cao X, Suo R, Jiang ZS: Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med (Maywood). 2011, 236: 169-176. 10.1258\/ebm.2010.010308.","journal-title":"Exp Biol Med (Maywood)"},{"key":"483_CR34","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.2741\/2954","volume":"13","author":"AG Zenovich","year":"2008","unstructured":"Zenovich AG, Taylor DA: Atherosclerosis as a disease of failed endogenous repair. Front Biosci. 2008, 13: 3621-3636.","journal-title":"Front Biosci"},{"key":"483_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1476-511X-11-96","volume":"11","author":"LC Lima","year":"2012","unstructured":"Lima LC, Porto ML, Campagnaro BP, Tonini CL, Nogueira BV, Pereira TM, Vasquez EC, Meyrelles SS: Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice. Lipids Health Dis. 2012, 11: 96-10.1186\/1476-511X-11-96.","journal-title":"Lipids Health Dis"},{"key":"483_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1476-511X-10-155","volume":"10","author":"ML Porto","year":"2011","unstructured":"Porto ML, Lima LC, Pereira TM, Nogueira BV, Tonini CL, Campagnaro BP, Meyrelles SS, Vasquez EC: Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Lipids Health Dis. 2011, 10: 155-10.1186\/1476-511X-10-155.","journal-title":"Lipids Health Dis"},{"key":"483_CR37","doi-asserted-by":"publisher","first-page":"11629","DOI":"10.1074\/jbc.M111.338673","volume":"287","author":"J Oh","year":"2012","unstructured":"Oh J, Riek AE, Weng S, Petty M, Kim D, Colonna M, Cella M, Bernal-Mizrachi C: Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J Biol Chem. 2012, 287: 11629-11641. 10.1074\/jbc.M111.338673.","journal-title":"J Biol Chem"},{"key":"483_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejvs.2012.08.005","volume":"44","author":"S Shaikh","year":"2012","unstructured":"Shaikh S, Brittenden J, Lahiri R, Brown PA, Thies F, Wilson HM: Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg. 2012, 44: 491-497. 10.1016\/j.ejvs.2012.08.005.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"483_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","volume":"225","author":"JL Stoger","year":"2012","unstructured":"Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, Biessen EA, Daemen MJ, Lutgens E, de Winther MP: Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012, 225: 461-468. 10.1016\/j.atherosclerosis.2012.09.013.","journal-title":"Atherosclerosis"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/scrt346\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:09:20Z","timestamp":1728382160000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/scrt346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/scrt346","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2013,11,1]]},"assertion":[{"value":"19 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"135"}}